1
10.51
-0.25 (-2.32%)
| Penutupan Terdahulu | 10.76 |
| Buka | 10.57 |
| Jumlah Dagangan | 2,591,818 |
| Purata Dagangan (3B) | 2,601,551 |
| Modal Pasaran | 1,285,394,048 |
| Harga / Jualan (P/S) | 1.66 |
| Harga / Buku (P/B) | 1.46 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Apr 2025 - 2 May 2025 |
| Margin Keuntungan | -29.90% |
| Margin Operasi (TTM) | -30.20% |
| EPS Cair (TTM) | -1.52 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -10.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.63% |
| Nisbah Semasa (MRQ) | 4.97 |
| Aliran Tunai Operasi (OCF TTM) | 6.66 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 59.82 M |
| Pulangan Atas Aset (ROA TTM) | -12.77% |
| Pulangan Atas Ekuiti (ROE TTM) | -25.17% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Bercampur |
| Health Information Services (Global) | Menurun | Bercampur | |
| Stok | 10x Genomics, Inc. | Menurun | Menurun |
AISkor Stockmoo
-0.1
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | -0.13 |
|
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.90% |
| % Dimiliki oleh Institusi | 99.74% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Venrock Management Vi, Llc | 30 Sep 2024 | 2,106,757 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 26.00 (Morgan Stanley, 147.38%) | Beli |
| Median | 14.50 (37.96%) | |
| Rendah | 12.00 (Barclays, 14.18%) | Beli |
| 12.00 (JP Morgan, 14.18%) | Pegang | |
| 12.00 (Leerink Partners, 14.18%) | Pegang | |
| Purata | 15.88 (51.09%) | |
| Jumlah | 5 Beli, 3 Pegang | |
| Harga Purata @ Panggilan | 11.28 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 10 Apr 2025 | 12.00 (14.18%) | Beli | 7.70 |
| 14 Feb 2025 | 15.00 (42.72%) | Beli | 12.32 | |
| Citigroup | 04 Mar 2025 | 15.00 (42.72%) | Beli | 10.52 |
| 13 Feb 2025 | 20.00 (90.29%) | Beli | 11.94 | |
| Morgan Stanley | 14 Feb 2025 | 26.00 (147.38%) | Beli | 12.32 |
| Canaccord Genuity | 13 Feb 2025 | 18.00 (71.27%) | Beli | 11.94 |
| JP Morgan | 13 Feb 2025 | 12.00 (14.18%) | Pegang | 11.94 |
| Leerink Partners | 13 Feb 2025 | 12.00 (14.18%) | Pegang | 11.94 |
| Stifel | 13 Feb 2025 | 18.00 (71.27%) | Beli | 11.94 |
| UBS | 13 Feb 2025 | 14.00 (33.21%) | Pegang | 11.94 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 30 Apr 2025 | Pengumuman | 10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference |
| 14 Apr 2025 | Pengumuman | 10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025 |
| 03 Mar 2025 | Pengumuman | 10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products |
| 23 Feb 2025 | Pengumuman | 10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis |
| 18 Feb 2025 | Pengumuman | 10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference |
| 12 Feb 2025 | Pengumuman | 10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |